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ABSTRACT
Hallervorden Spatz disease, also known as pantothenate kinase associated neuro-degeneration, is a rare, progressive 
neurological disorder usually seen in first decade of life. It is associated with extrapyramidal effects, dysarthria and 
dementia. Hallervorden Spatz Disease is also associated with psychiatric symptoms, depression and behavioral 
changes. Affected patients are disabled predominantly by dystonia. MRI, in later stage of the disease, shows “eye of the 
tiger’ appearance which is fairly diagnostic of Hallervorden Spatz Disease. Response to drugs is often poor and of limited 
value to these patients. This report highlights a classical case of Hallervorden Spatz disease that presented as an outpa-
tient with dystonia and psychotic symptoms and was diagnosed on the basis of clinical and radiological evidence.
CASE REPORT
A 9 years old boy, with no previous significant medical 
history, presented to Neurology as an outpatient on 20th 
February 2014 with a 3 years history of abnormal move-
ments of all limbs and trunk, ataxic gait, cognitive impair-
ment and psychomotor agitation. Three years back, he 
was perfectly healthy, both mentally and physically, 
studying in second grade. At the age of six, his family 
noticed behavioral changes including hyperphagia, 
general irritability and impulsiveness, irrelevant talk, 
muttering to himself and occasional episodes of aggres-
siveness. He had once burnt himself and at another 
occasion put his hand in the blender. After few months, 
he developed abnormal movements first noticed in the 
lower limb which gradually progressed to the rest of the 
body. There was no preceding history of fever, use of any 
drugs, jaundice, incontinence, seizures or any focal 
deficit. He is the youngest, born to first degree consan-
guineous parents. He has 13 siblings, all of whom are 
physically and mentally healthy. He was born via a 
full-term spontaneous vaginal delivery, with normal child-
hood milestones, fully vaccinated and no previous history 
of hospitalization or any significant illness. On Examina-
tion, he had a blank facial expression. He had general-
ized dystonia, marked in right upper limb. He had burn 
scars on his arm and neck. He had a tip-toe walk and 
ataxic gait. His lower limb reflexes were brisk, MRI brain 
showed bilateral basal ganglia hypodensities with 
centrally placed area of hyperdensity, also known as the 
“eye of the tiger’ appearance, mostly seen in patients 
with Hallervorden Spatz disease. His further investiga-
tions included those needed to rule out Wilson’s disease, 
ceruloplasmin, copper, ferritin; Vitamin B12 levels and 
amino acid chromatography were within normal range. 
(Table1)  His ophthalmological examination done for 
Kayser – Fleischer ring and retinitis pigmentosa was 
normal. His peripheral film was unremarkable. His blood 
iron levels were slightly decreased and his post exercise 
lactic acid was elevated at 1:4 ratios. 
Table 1: Pertinent Investigations
2 9 V O L .  9  ( 2 )  A P R  -  J U N  2 0 1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
C A S E  R E P O R T
Tests Results Reference Range
Serum Iron levels 31 μg/dL Male 65-175 μg/dL 
Vitamin B12 levels 47.4 pmol/L 25-165pmol/L 
Ceruloplasmin levels 23 mg/dL 20-60 mg/dL 
Copper Serum 103.02 ug/dL Children(6 Years) 90-190 ug/dL
  Children(12 Years) 80-160 ug/dL
Obligate Features Collaborate Features Exclusion Features
Onset during first two decades Pyramidal tract signs Non progressive nature of the
of life   disease
Progressive nature of the Progressive cognitive Family history positive for 
disease impairment Huntington’s disease, caudate
  atrophy or autosomal
  dominant movement disorder 
Extra-pyramidal dysfunction seizures Absence of extrapyramidal signs 
 Retinitis pigmentosa Predominant epileptic episode
 Positive family history Abnormal ceruloplasmin or 
  copper level
 Hypodensity in basal ganglia 
 on MRI brain
 Abnormal cytoplasm in 
 lymphocytes
 Sea blue histocytes on bone
 marrow 
Lactic Acid (pre-exercise) 10.9mg/dL 4.5-19.8 mg/dL 
 45.1mg/dL
Lactic Acid (post exercise)
Ferritin levels 101.71ng/mL Male 22.0-275.0 ng/mL 
  Female 5.0-204.0 ng/mL 
Amino acid  Unremarkable Unremarkable 
Chromatography
He was diagnosed as Hallervorden Spatz disease. The 
family was counselled about the progression and prog-
nosis of the disease. He was given a trial of Trihexipheni-
dyl, clonazepam and baclofen. The patient on follow up 
was neurologically the same but dystonia had improved 
slightly.
DISCUSSION
Hallervorden Spatz disease is an autosomal recessive 
disease, first described by Julius Hallervorden and Hugo 
Spatz in 1922 (1). In most cases, defect lies in the gene 
coding for pantothenate kinase 2 (PANK2) located on 
chromosome 20p13-p12.3 (2). This gene causes iron 
storage in brain, which in the presence of oxygen, 
causes degeneration of the nervous system (3). However, 
in 15% of people it may be sporadic (4).One of the limita-
tions of the case is that we were unable to do genetic 
studies due to limited resources.
The symptoms of Hallervorden Spatz Disease are usually 
found between 7-15 years of age. The disease has also 
been reported in infancy and adults (5, 6). Very few cases of 
this disease have been reported in Pakistan (7). The 
diagnostic criteria for HSD consist of three obligate, two or 
more collaborate and none of the exclusion features, as 
shown in table 2.
CT scan findings are non specific. MRI in early stage of 
the disease may be normal, later, however, it may be 
helpful in diagnosis. MRI shows bilateral symmetrical 
hyperintense signal changes in anterior globus pallidus 
with a surrounding hypointensity as shown in Figure 1. 
The hypointensity is due to loss of signals secondary to 
iron deposition and hyperintensity is a result of various 
pathological changes including axonal swelling and 
demyelination. These imaging features are fairly 
diagnostic of HSD 8.
Table 2: Diagnostic Features (3)
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There is no known cure for this disease. Hence the treat-
ment is mainly directed towards managing symptoms of 
the patient. Studies suggest safety of desferrioxamine as 
chelating agents for iron accumulation in the brain, but 
there has been no study so far proving its beneficial role 
(9). Anti-Parkinson’s drugs including levodopa, bromocrip
Figure 1: MRI Brain (a) Coronal T2 W image (b) axial 
FLAIR image showing bilateral symmetrical hyperintense 
signal changes in anterior globus pallidus with a 
surrounding hypointensity. 
tine and anticholinergics, have been used for extrapy-
ramidal effects in patients. Baclofen has also been used 
for dystonia and has been of limited benefit to these 
patients. Use of conventional antipsychotics for psychiat-
ric symptoms has not been recommended, however, 
there are studies on efficacy of clozapine and atypical 
antipsychotics (10). 
CONCLUSION
Unfortunately, there is limited literature on Hallervorden 
Spatz disease and more studies need to be done for full 
understanding of the disease and management.  
Because the disease is rare, reporting such cases would 
benefit the practicing neurologist to be familiarized with 
this rare disease.
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